In the last trading session, 1.78 million Protagenic Therapeutics Inc (NASDAQ:PTIX) shares changed hands as the company’s beta touched 0. With the company’s per share price at $0.53 changed hands at -$0.07 or -10.91% during last session, the market valuation stood at $3.32M. PTIX’s last price was a discount, traded about -252.83% off its 52-week high of $1.87. The share price had its 52-week low at $0.45, which suggests the last value was 15.09% up since then. When we look at Protagenic Therapeutics Inc’s average trading volume, we note the 10-day average is 0.26 million shares, with the 3-month average coming to 209.64K.
Protagenic Therapeutics Inc (NASDAQ:PTIX) trade information
Instantly PTIX was in red as seen at the end of in last trading. With action 3.79%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -46.00%, with the 5-day performance at 3.79% in the green. However, in the 30-day time frame, Protagenic Therapeutics Inc (NASDAQ:PTIX) is -12.07% down. Looking at the short shares, we see there were 89119.0 shares sold at short interest cover period of 1.33 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -2.91%.
PTIX Dividends
Protagenic Therapeutics Inc is expected to release its next quarterly earnings report in January.
Protagenic Therapeutics Inc (NASDAQ:PTIX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.25% of Protagenic Therapeutics Inc shares while 5.77% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.73%.
